Syenza Resources
Adapting PRISMA for Simulation Models in Healthcare
This adapted PRISMA connects evidence synthesis with dynamic modeling. It supports informed decisions through reproducible processes. Ready to learn more? Download the poster today!
From Economics
to Access: The State of Biosimilars
Biosimilars delivered $23.6 billion in US savings (2015–2023) and are projected to reach an $88 billion global market by 2030. Learn about cost dynamics, competitive trends, and patient outcomes.
